Study design
Observational
Sample size
80 Participants
Study sites
Bispebjerg Hospital and the patient’s own homes
Inclusion criteria
Adult patients (≥ 18 years) admitted with an acute medical disease and who are scheduled for discharge to their own homes within five days from inclusion.
Study procedures
Included patients are monitored with WARD equipment during the last part of hospitalization and the first days after discahrge. Monitoring will last for a maximum of eight days.
Primary outcome
Minutes during the measurement period with complete data from the LifeTouch device.
Primary investigator
Vibeke Eriksen, MD, Ph.d.
NCT link
NCT05223504